EQUIRAB 5 ML INJECTION VIAL 5 ML

How EQUIRAB 5 ML INJECTION VIAL 5 ML Works

• EQUIRAB 5 ML INJECTION VIAL 5 ML contains antibodies that bind to the rabies virus, preventing it from entering and infecting the body's cells.
• When EQUIRAB 5 ML INJECTION VIAL 5 ML is administered, the antibodies it contains recognize and bind to the rabies virus present in the body. This binding prevents the virus from attaching to and infecting the cells, effectively neutralizing its harmful effects. The antibodies present in the serum work by targeting specific viral components, such as the glycoprotein spikes on the surface of the rabies virus. By binding to these spikes, the antibodies prevent the virus from entering cells and replicating. Additionally, the serum contains a high concentration of antibodies, providing passive immunity to the patient, especially in cases where the individual has not been previously vaccinated against rabies. The EQUIRAB 5 ML INJECTION VIAL 5 ML is typically administered along with the rabies vaccine to ensure a comprehensive immune response. This combination approach helps prevent the virus from spreading and allows the patient's own immune system to develop a long-lasting protective response.

• Allergic reactions
• Injection site reactions

• Keep EQUIRAB INJ VIAL 5ML away from the reach of children and pets.
• Store EQUIRAB INJ VIAL 5ML in a refrigerator (2 - 8°C). Do not freeze.